Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-23-035262
Filing Date
2023-12-22
Accepted
2023-12-22 17:00:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 mbrx20231110_424b5.htm 424B5 349307
2 m01.jpg GRAPHIC 5010
  Complete submission text file 0001437749-23-035262.txt   357313
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256627 | Film No.: 231510636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)